PropertyValue
?:abstract
  • COVID results in a variety of pathophysiology that causes cardiorespiratory and the need for ECMO. These include hypoxic respiratory failure, cardiogenic shock, cardiac arrest, multisystem inflammatory disease, and vascular thrombosis with pulmonary embolism. A variety of cannulation strategies are required and the \'hyperinflammation\' and consequent coagulation abnormalities mandate new strategies to provide optimal ECMO support.
?:creator
?:doi
  • 10.1177/0267659120986760
?:doi
?:journal
  • Perfusion
?:license
  • unk
?:pmid
?:pmid
  • 33412976
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • COVID-19: A new challenge for ECMO.
?:type
?:year
  • 2021-01-07

Metadata

Anon_0  
expand all